Is the Regulatory Situation in Europe Improving for Biologicals?

Collaboration poised to accelerate adoption of cost-effective mycorrhizal inoculants to one of the world’s largest agricultural markets.

Success depends on strategic partnerships, navigating national regulations, and aligning with EU sustainability goals.

From innovative formulations to diversified portfolios, here are five biological trends to watch in 2025, according to Accumont Advisors’ Peter Chalmers.

As regulatory pressures increase and conventional products face restrictions, biostimulants offer promising solutions.

Brändle shares what to consider when entering a new market, what African countries to keep an eye on, and how Elephant Vert grew globally.

GreenLight Biosciences’ Mark Singleton shares insight into the company’s long-term vision to make RNA technology a cornerstone of sustainable agriculture.

Acquisition strengthens Andermatt’s position as a leading provider of biological plant protection solutions and expands its product portfolio.

Staphyt’s Geoffroy Moulin highlights the EU’s push to fast-track biocontrol product approvals, despite ongoing challenges.

AXPERA is an amoeba lysate-based biofungicide for combating fungal diseases.